Grace Harrington

Roswell Park Comprehensive Cancer Center

Papers

3

Total Citations

11

H-Index

3

About

Grace Harrington is a leading urologic oncologist whose research centers on optimizing surgical outcomes for patients undergoing robot-assisted radical cystectomy (RARC) for bladder cancer. Her work focuses on three critical areas: preventing postoperative complications, refining surgical techniques, and improving long-term functional outcomes. Harrington’s most impactful contributions include a randomized controlled trial demonstrating that prophylactic antibiotics do not reduce 90-day urinary tract infection rates after RARC—a finding that challenges routine clinical practice and could spare patients unnecessary medication. She has also pioneered robot-assisted uretero-enteric reimplantation for strictures, reporting outcomes from a two-decade institutional experience at Roswell Park Comprehensive Cancer Center, establishing this minimally invasive approach as a durable solution for a challenging complication. Additionally, her investigation into stent-free ureteroenteric anastomosis suggests that omitting stents may lower stricture rates without increasing other risks. With over a decade of dedicated research, Harrington’s work has earned citations in leading urology journals, directly influencing evidence-based guidelines for cystectomy care. Her commitment to rigorous, patient-centered research continues to shape the standard of care in robotic bladder cancer surgery.

Research Focus

Key Achievements

3
H-Index
3
Papers
11
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Do Prophylactic Antibiotics Decrease the Rate of Urinary Tract Infections After Robot-Assisted Radical Cystectomy? A Randomized Controlled Trial
4 citations · 2025
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Roswell Park Comprehensive Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago